SARS-CoV-2 Vaccine Shows Signs of Activity in Phase 1/2 Study
BNT162b1, a SARS-CoV-2 vaccine candidate, elicited promising early signs of immune activity in a placebo-controlled phase 1/2 study.
FDA Authorizes 5-Minute SARS-CoV-2 Test
FDA grants emergency use authorization for a new rapid point-of-care molecular SARS-CoV-2 diagnostic.
FDA Authorizes Rapid Point-of-Care SARS-CoV-2 Diagnostic
FDA grants emergency use authorization for Cepheid's point-of-care COVID-19 diagnostic, Xpert Xpress SARS-CoV-2.
Gottlieb Addresses Coronavirus at Miami Breast Cancer Conference
"We're going to have to figure out what our American approach is to this to and how we're going to take more aggressive mitigation steps," Scott Gottlieb, MD, said in his keynote address.
FDA Approves New Treatment for Adults with Complicated Urinary Tract Infections
The FDA approves meropenem-vaborbactam (Vabomere) for the treatment of adult patients with complicated urinary tract infections, including those with pyelonephritis.
Republicans Push Bill to Replace Obamacare
Republicans in the House of Representatives have proposed a replacement bill for the Affordable Care Act (ACA) labeled the American Health Care Act.
2 Clarke Drive Cranbury, NJ 08512